<p>(A) The rate constant of force redevelopment at various [Pi] for perfused (circles) and ischemic (triangles) fibers, with (open symbols) and without (closed symbols) 8-Br-cAMP treatment. * <i>P</i><0.05 compared to the control perfused condition. (B) The change in the force per cross-sectional area for perfused and ischemic fibers treated with 8-Br-cAMP. Data presented are average ± S.E.M. * <i>P</i><0.05 compared to untreated ischemic fibers.</p
<p>The root-mean-squared (RMS) amplitude for the initial driving oscillation (a) and the final drivi...
<p>(A) Sample records recorded during a typical experiment in a fibre activated in pCa<sup>2+</sup>4...
<p>Simultaneous recordings of stiffness (upper records) and force (lower records) during the develop...
<p>(A) Representative traces of force after length release for a perfused fiber activated by pCa4.5 ...
<p>(A) Force per cross-sectional area versus Ca<sup>2+</sup> concentration for perfused (•), ischemi...
<p>(A) Typical force transients from representative perfused, ischemic and ischemia-reperfused fiber...
<p>[A] Number of fibres tested. [B] Cross-sectional area (CSA). [C] Maximal force production normali...
<p>Data are presented as average ± S.E.M.</p><p>*: denotes <i>P</i><0.016 compared to perfused fiber...
<p>(A) Typical force transients from a representative perfused and ischemic fiber activated from Ca<...
<p>A) Examples of <i>k<sub>tr</sub></i> experiments on WT and NEB KO fiber bundles activated at pCa ...
<p>(A) Superimposed contractions showing the force increase during stretch (top) when the fibre was ...
<p>Legend: (i) first set of experiment, with fibers activated at four Ca<sup>2+</sup> concentrations...
<p>(A) Superimposed contractions showing the force increase during stretch while the fibre was activ...
<p>A: In-vitro data for the force dependence of proliferation rates are shown for two different appl...
<p>(A) Sample records from a typical experiment showing superimposed contractions produced by a fibr...
<p>The root-mean-squared (RMS) amplitude for the initial driving oscillation (a) and the final drivi...
<p>(A) Sample records recorded during a typical experiment in a fibre activated in pCa<sup>2+</sup>4...
<p>Simultaneous recordings of stiffness (upper records) and force (lower records) during the develop...
<p>(A) Representative traces of force after length release for a perfused fiber activated by pCa4.5 ...
<p>(A) Force per cross-sectional area versus Ca<sup>2+</sup> concentration for perfused (•), ischemi...
<p>(A) Typical force transients from representative perfused, ischemic and ischemia-reperfused fiber...
<p>[A] Number of fibres tested. [B] Cross-sectional area (CSA). [C] Maximal force production normali...
<p>Data are presented as average ± S.E.M.</p><p>*: denotes <i>P</i><0.016 compared to perfused fiber...
<p>(A) Typical force transients from a representative perfused and ischemic fiber activated from Ca<...
<p>A) Examples of <i>k<sub>tr</sub></i> experiments on WT and NEB KO fiber bundles activated at pCa ...
<p>(A) Superimposed contractions showing the force increase during stretch (top) when the fibre was ...
<p>Legend: (i) first set of experiment, with fibers activated at four Ca<sup>2+</sup> concentrations...
<p>(A) Superimposed contractions showing the force increase during stretch while the fibre was activ...
<p>A: In-vitro data for the force dependence of proliferation rates are shown for two different appl...
<p>(A) Sample records from a typical experiment showing superimposed contractions produced by a fibr...
<p>The root-mean-squared (RMS) amplitude for the initial driving oscillation (a) and the final drivi...
<p>(A) Sample records recorded during a typical experiment in a fibre activated in pCa<sup>2+</sup>4...
<p>Simultaneous recordings of stiffness (upper records) and force (lower records) during the develop...